6/27/24 16:55 | 6/27/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | M.d | 222 | 3.73 | 0 | 60 | 2 | 3,599 | D | | | | | | | | | | | | | | |
5/28/24 17:55 | 5/24/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 1,060 | 4.42 | 0 | 240 | 7 | 3,537 | D | | | | | | | | | | | | | | |
4/9/24 18:38 | 4/7/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 36 | 1 | 3,170 | D | | | | | | | | | | | | | | |
3/29/24 16:52 | 3/27/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | M.d | 907 | 3.72 | 0 | 244 | 8 | 3,152 | D | | | | | | | | | | | | | | |
3/25/24 07:07 | 3/22/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 1,168 | 5.19 | 0 | 225 | 8 | 2,909 | D | | | | | | | | | | | | | | |
2/20/24 18:22 | 2/15/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 37 | 1 | 2,684 | D | | | | | | | | | | | | | | |
1/3/24 17:42 | 1/2/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 33 | 1 | 2,665 | D | | | | | | | | | | | | | | |
12/13/23 15:25 | 12/12/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | CEO | P | 1,010 | 5.05 | 0 | 200 | 8 | 2,645 | D | | | | | | | | | | | | | | |
12/11/23 19:24 | 12/7/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | CEO | M.d | 0 | 0.00 | 0 | 27 | 1 | 2,445 | D | | | | | | | | | | | | | | |
11/13/23 08:00 | 11/10/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 406 | 4.27 | 0 | 95 | 4 | 2,428 | D | | | | | | | | | | | | | | |
8/15/23 16:56 | 8/14/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P.d | 247 | 5.48 | 0 | 45 | 2 | 2,333 | D | | | | | | | | | | | | | | |
6/12/23 16:47 | 6/9/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | CEO | P | 520 | 4.52 | 0 | 115 | 5 | 2,574 | D | | | | | | | | | | | | | | |
5/15/23 16:02 | 5/12/23 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | CEO | P | 1,496 | 3.40 | 0 | 440 | 22 | 2,438 | D | | | | | | | | | | | | | | |
12/14/22 17:00 | 12/12/22 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 565 | 3.77 | 0 | 150 | 9 | 1,838 | D | | | | | | | | | | | | | | |
12/1/22 18:00 | 11/30/22 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 1,016 | 3.39 | 0 | 300 | 21 | 1,705 | D | | | | | | | | | | | | | | |
11/9/22 20:30 | 11/9/22 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Foehr Matthew W | CA | DO | P,CEO | P | 276 | 2.76 | 0 | 100 | 8 | 1,405 | D | | | | | | | | | | | | | | |
5/13/22 19:05 | 5/13/22 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | P | 207 | 82.76 | 0 | 3 | 1 | 173 | D | | | | | | | | | | | | | | |
5/3/22 16:12 | 5/2/22 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 111 | 2.47 | 0 | 45 | 68 | 111 | D | | | | | | | | | | | | | | |
11/12/21 16:54 | 11/11/21 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 348 | 28.54 | 0 | 12 | 8 | 167 | D | | | | | | | | | | | | | | |
11/12/21 16:54 | 11/11/21 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -1,819 | 163.02 | 0 | -11 | -6 | 167 | D | | | | | | | | | | | | | | |
8/5/21 16:44 | 8/4/21 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 292 | 29.23 | 0 | 10 | 6 | 165 | D | | | | | | | | | | | | | | |
8/5/21 16:44 | 8/4/21 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -970 | 109.67 | 0 | -9 | -5 | 165 | D | | | | | | | | | | | | | | |
6/10/21 16:57 | 6/10/21 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 114 | 5.69 | 0 | 20 | 43 | 66 | D | | | | | | | | | | | | | | |
6/1/21 16:59 | 5/28/21 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 99 | 56.26 | 0 | 2 | 1 | 164 | D | | | | | | | | | | | | | | |
2/5/21 17:03 | 2/4/21 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 1,051 | 23.07 | 0 | 46 | 37 | 168 | D | | | | | | | | | | | | | | |
2/5/21 17:03 | 2/4/21 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -7,879 | 176.86 | 0 | -45 | -21 | 168 | D | | | | | | | | | | | | | | |
8/25/20 19:10 | 8/21/20 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.dm | 165 | 20.39 | 0 | 8 | 5 | 155 | D | | | | | | | | | | | | | | |
8/25/20 19:10 | 8/21/20 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.dm | -824 | 112.86 | 0 | -7 | -4 | 155 | D | | | | | | | | | | | | | | |
6/30/20 17:54 | 6/30/20 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | S | -96 | 7.35 | 0 | -13 | -33 | 26 | D | | | | | | | | | | | | | | |
3/13/20 18:33 | 3/13/20 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 44 | 21.92 | 0 | 2 | 1 | 157 | D | | | | | | | | | | | | | | |
2/27/20 20:35 | 2/27/20 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 142 | 15.89 | 0 | 9 | 6 | 155 | D | | | | | | | | | | | | | | |
2/27/20 20:35 | 2/27/20 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -795 | 110.00 | 0 | -7 | -4 | 155 | D | | | | | | | | | | | | | | |
2/18/20 17:09 | 2/13/20 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.dm | 115 | 14.95 | 0 | 8 | 5 | 154 | D | | | | | | | | | | | | | | |
2/18/20 17:09 | 2/14/20 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -692 | 95.84 | 0 | -7 | -4 | 154 | D | | | | | | | | | | | | | | |
11/13/19 16:07 | 11/12/19 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 22 | 21.92 | 0 | 1 | 1 | 145 | D | | | | | | | | | | | | | | |
9/5/19 19:24 | 9/5/19 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 22 | 21.92 | 0 | 1 | 1 | 144 | D | | | | | | | | | | | | | | |
8/13/19 13:45 | 8/12/19 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 25 | 21.92 | 0 | 1 | 1 | 143 | D | | | | | | | | | | | | | | |
6/12/19 18:50 | 6/11/19 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 22 | 21.92 | 0 | 1 | 1 | 141 | D | | | | | | | | | | | | | | |
3/15/19 14:00 | 3/14/19 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 148 | 9.97 | 0 | 15 | 12 | 140 | D | | | | | | | | | | | | | | |
12/12/18 17:32 | 12/12/18 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 80 | 9.97 | 0 | 8 | 8 | 113 | D | | | | | | | | | | | | | | |
10/2/18 18:24 | 10/1/18 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 194 | 13.80 | 0 | 14 | 15 | 105 | D | | | | | | | | | | | | | | |
10/2/18 18:24 | 10/1/18 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -3,287 | 273.88 | 0 | -12 | -10 | 105 | D | | | | | | | | | | | | | | |
9/19/18 14:19 | 8/17/18 | RTTR | Ritter Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P.a | 40 | 2.04 | 0 | 20 | 564 | 23 | D | | | | | | | | | | | | | | |
9/5/18 20:18 | 9/4/18 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 184 | 14.11 | 0 | 13 | 14 | 103 | D | | | | | | | | | | | | | | |
9/5/18 20:18 | 9/4/18 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -3,060 | 255.01 | 0 | -12 | -10 | 103 | D | | | | | | | | | | | | | | |
8/20/18 17:19 | 8/17/18 | RTTR | Ritter Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 40 | 2.04 | 0 | 20 | 56 | 55 | D | | | | | | | | | | | | | | |
5/11/18 17:32 | 5/10/18 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 139 | 13.99 | 0 | 10 | 11 | 102 | D | | | | | | | | | | | | | | |
5/11/18 17:32 | 5/10/18 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -1,489 | 167.63 | 0 | -9 | -8 | 102 | D | | | | | | | | | | | | | | |
2/27/18 18:39 | 2/23/18 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 89 | 13.77 | 0 | 6 | 7 | 96 | D | | | | | | | | | | | | | | |
2/27/18 18:39 | 2/23/18 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -833 | 152.98 | 0 | -5 | -5 | 96 | D | | | | | | | | | | | | | | |
8/10/17 18:40 | 8/9/17 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 69 | 9.97 | 0 | 7 | 8 | 96 | D | | | | | | | | | | | | | | |
8/10/17 18:40 | 8/9/17 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -778 | 127.51 | 0 | -6 | -6 | 96 | D | | | | | | | | | | | | | | |
5/18/17 15:39 | 5/18/17 | RTTR | Ritter Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 11 | 0.6197 | 1 | 18 | 106 | 35 | D | | -64 | -73 | -82 | -56 | -39 | -14 | -5 | | | | | | |
5/15/17 19:05 | 5/12/17 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.dm | 78 | 9.97 | 22 | 8 | 9 | 95 | D | 35 | -3 | 8 | 6 | 7 | 7 | 1 | -2 | | | | | | |
5/15/17 19:05 | 5/12/17 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -631 | 112.20 | 22 | -6 | -6 | 95 | D | 35 | -3 | 8 | 6 | 7 | 7 | 1 | -2 | | | | | | |
3/3/17 18:54 | 3/2/17 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.dm | 89 | 9.97 | 33 | 9 | 11 | 93 | D | 53 | 5 | -2 | -3 | 1 | -6 | -3 | -5 | 2 | 5 | 2 | | | |
3/3/17 18:54 | 3/2/17 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -711 | 103.39 | 33 | -7 | -7 | 93 | D | 53 | 5 | -2 | -3 | 1 | -6 | -3 | -5 | 2 | 5 | 2 | | | |
11/15/16 16:34 | 11/15/16 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 16 | 1.21 | 0 | 13 | 50 | 39 | D | | -76 | -2 | -9 | -16 | 16 | 22 | 16 | -1 | -2 | -10 | 32 | | |
8/9/16 16:58 | 8/5/16 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.dm | 166 | 9.97 | 33 | 17 | 25 | 83 | D | 133 | 25 | 32 | -3 | 4 | -8 | -13 | -12 | -2 | -2 | -1 | -21 | -7 | |
8/9/16 16:58 | 8/5/16 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -1,527 | 122.14 | 33 | -13 | -13 | 83 | D | 133 | 25 | 32 | -3 | 4 | -8 | -13 | -12 | -2 | -2 | -1 | -21 | -7 | |
4/13/16 18:17 | 4/13/16 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P.d | 25 | 1.24 | 1 | 20 | 320 | 26 | D | | | -79 | -53 | -27 | -18 | -8 | -30 | -2 | -3 | 0 | 4 | 3 | |
3/17/16 19:56 | 3/17/16 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 86 | 9.97 | 33 | 9 | 12 | 79 | D | 27 | 32 | 0 | -6 | -4 | 3 | -5 | -4 | 2 | 4 | 28 | 18 | 19 | 12 |
3/17/16 19:56 | 3/17/16 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -619 | 96.70 | 33 | -6 | -8 | 79 | D | 27 | 32 | 0 | -6 | -4 | 3 | -5 | -4 | 2 | 4 | 28 | 18 | 19 | 12 |
1/11/16 16:40 | 1/8/16 | RTTR | Ritter Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 21 | 1.64 | 0 | 13 | 325 | 17 | D | | | -64 | -36 | -31 | -7 | -13 | -5 | 3 | -2 | -19 | -2 | 11 | 100 |
6/30/15 17:39 | 6/26/15 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.dm | 150 | 9.97 | 33 | 15 | 26 | 73 | D | 165 | 57 | 83 | 27 | 10 | 4 | 1 | -2 | -4 | -3 | 6 | -19 | 6 | 17 |
6/30/15 17:39 | 6/26/15 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -1,262 | 100.97 | 33 | -13 | -15 | 73 | D | 165 | 57 | 83 | 27 | 10 | 4 | 1 | -2 | -4 | -3 | 6 | -19 | 6 | 17 |
6/25/15 20:56 | 6/24/15 | RTTR | Ritter Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 20 | 5.00 | 4 | 4 | New | 4 | D | | | | | | | | | -2 | -4 | -13 | -37 | -57 | -62 |
6/24/15 18:52 | 6/22/15 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | M.d | 250 | 9.97 | 33 | 25 | 56 | 70 | D | 186 | 60 | 90 | 33 | 18 | 9 | 6 | 4 | 2 | 2 | 5 | -2 | 9 | 15 |
6/24/15 18:52 | 6/22/15 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | P,COO | S.d | -2,223 | 96.45 | 33 | -23 | -25 | 70 | D | 186 | 60 | 90 | 33 | 18 | 9 | 6 | 4 | 2 | 2 | 5 | -2 | 9 | 15 |
5/5/15 13:47 | 5/4/15 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | D | | P | 50 | 8.00 | 1 | 6 | New | 6 | D | | | | | | | | 6 | 0 | -1 | -17 | -31 | -41 | -86 |
1/5/15 19:46 | 12/31/14 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | P | 2 | 45.23 | 13 | 0 | 0 | 55 | D | 159 | 4 | -17 | 18 | 0 | 0 | -1 | 3 | -2 | 3 | 2 | 41 | 85 | 91 |
10/14/14 13:48 | 10/10/14 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | P.d | 4 | 44.91 | 23 | 0 | 0 | 55 | D | 158 | -6 | -26 | -21 | -16 | -5 | -2 | 2 | 2 | 12 | 27 | 16 | 90 | 95 |
10/14/14 13:48 | 10/13/14 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | M.d | 10 | 9.97 | 23 | 1 | 2 | 55 | D | 158 | -6 | -26 | -21 | -16 | -5 | -2 | 2 | 2 | 12 | 27 | 16 | 90 | 95 |
7/1/14 12:16 | 6/30/14 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | P | 19 | 43.79 | 19 | 0 | 1 | 54 | D | 308 | 67 | 15 | -7 | -4 | -10 | -5 | -1 | 2 | -1 | -18 | -24 | -16 | 62 |
2/14/14 20:00 | 2/14/14 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | M.d | 259 | 9.97 | 26 | 26 | 94 | 53 | D | 438 | 281 | 80 | 63 | 54 | 31 | 33 | 26 | -4 | -3 | 0 | -16 | -28 | -27 |
2/14/14 20:00 | 2/14/14 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | S.d | -1,790 | 79.54 | 26 | -23 | -30 | 53 | D | 438 | 281 | 80 | 63 | 54 | 31 | 33 | 26 | -4 | -3 | 0 | -16 | -28 | -27 |
1/2/14 16:48 | 12/31/13 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | P | 3 | 33.92 | 15 | 0 | 0 | 45 | D | 347 | 154 | 36 | 16 | 1 | -2 | -1 | -3 | 1 | 7 | 20 | 28 | 23 | 3 |
12/13/13 18:46 | 12/12/13 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | M.d | 60 | 9.97 | 27 | 6 | 15 | 45 | D | 332 | 177 | 61 | 13 | 2 | 2 | -1 | -2 | -1 | 2 | 18 | 46 | 23 | 0 |
12/13/13 18:46 | 12/12/13 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | S.d | -320 | 53.40 | 27 | -6 | -12 | 45 | D | 332 | 177 | 61 | 13 | 2 | 2 | -1 | -2 | -1 | 2 | 18 | 46 | 23 | 0 |
7/1/13 15:27 | 6/28/13 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | P | 18 | 17.36 | 11 | 1 | 2 | 45 | D | 218 | 145 | 74 | 41 | 34 | 17 | 16 | 4 | 7 | 14 | 28 | 14 | 45 | 67 |
12/5/12 16:53 | 12/5/12 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | EVP,COO | P | 7 | 17.99 | 3 | 0 | 1 | 38 | D | 120 | 59 | 51 | 8 | 20 | 5 | -2 | -6 | 0 | 8 | 7 | 25 | 70 | 198 |
3/3/06 12:44 | 3/1/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | M.d | 47 | 12.45 | 0 | 4 | 10 | 42 | D | | | | | | | | | | | | | | |
3/3/06 12:44 | 3/1/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | S.d | -63 | 16.46 | 0 | -4 | -8 | 42 | D | | | | | | | | | | | | | | |
3/3/06 12:44 | 2/1/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | M.ad | 87 | 12.45 | 0 | 7 | 20 | 42 | D | | | | | | | | | | | | | | |
3/3/06 12:44 | 2/1/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | S.ad | -105 | 14.99 | 0 | -7 | -14 | 42 | D | | | | | | | | | | | | | | |
2/3/06 18:02 | 2/3/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | S.d | -184 | 14.99 | 0 | -12 | -23 | 40 | D | | | | | | | | | | | | | | |
2/3/06 18:02 | 2/3/06 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | M.d | 56 | 10.70 | 0 | 5 | 15 | 40 | D | | | | | | | | | | | | | | |
4/20/05 20:11 | 4/18/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | M.dm | 186 | 15.58 | 0 | 12 | | 7 | D | | | | | | | | | | | | | | |
4/20/05 20:11 | 4/18/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | S.dm | -344 | 28.82 | 0 | -12 | -62 | 7 | D | | | | | | | | | | | | | | |
4/15/05 18:00 | 4/14/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | M.d | 1 | 6.00 | 0 | 0 | 1 | 7 | D | | | | | | | | | | | | | | |
4/15/05 18:00 | 4/14/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | S.d | -3 | 28.00 | 0 | 0 | -1 | 7 | D | | | | | | | | | | | | | | |
3/15/05 20:53 | 3/14/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | M.dm | 1 | 6.00 | 0 | 0 | 3 | 7 | D | | | | | | | | | | | | | | |
3/15/05 20:53 | 3/14/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | S.dm | -6 | 28.01 | 0 | 0 | -3 | 7 | D | | | | | | | | | | | | | | |
2/3/05 16:10 | 2/3/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | M.d | 62 | 12.45 | 0 | 5 | 215 | 7 | D | | | | | | | | | | | | | | |
2/3/05 16:10 | 2/3/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | S.d | -118 | 23.67 | 0 | -5 | -41 | 7 | D | | | | | | | | | | | | | | |
2/3/05 16:09 | 2/2/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | M.d | 132 | 8.81 | 0 | 15 | | 7 | D | | | | | | | | | | | | | | |
2/3/05 16:09 | 2/2/05 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | S.d | -363 | 24.20 | 0 | -15 | -67 | 7 | D | | | | | | | | | | | | | | |
12/12/03 18:46 | 12/11/03 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | M.m | 77 | 6.43 | 0 | 12 | | 6 | D | | | | | | | | | | | | | | |
12/12/03 18:46 | 12/11/03 | CNCT | Connetics Corp | DE | Health | Drug | Pharmaceutical Preparations | Foehr Matthew W | CA | O | SVP Tech | S.m | -195 | 16.23 | 0 | -12 | -67 | 6 | D | | | | | | | | | | | | | | |